Form 8-K - Current report:
SEC Accession No. 0001047469-02-005648
Filing Date
2002-12-04
Accepted
2002-12-04 16:27:33
Documents
5
Period of Report
2002-12-03
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2095474z8-k.txt 8-K 10456
3 EXHIBIT 2.1 a2095474zex-2_1.txt EX-2.1 238546
4 EXHIBIT 2.2 a2095474zex-2_2.txt EX-2.2 75475
5 EXHIBIT 2.3 a2095474zex-2_3.txt EX-2.3 39261
6 EXHIBIT 99.1 a2095474zex-99_1.txt EX-99.1 10601
  Complete submission text file 0001047469-02-005648.txt   376359
Mailing Address 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21589 | Film No.: 02848899
SIC: 2834 Pharmaceutical Preparations